✦ LIBER ✦

Pharmacokinetics of Concurrent Administration of Fosamprenavir and Atazanavir without Ritonavir in Human Immunodeficiency Virus-Negative Subjects

✍ Scribed by Dr. MaryPeace McRae; Dr. Patrick G. Clay; Dr. Peter L. Anderson; Dr. Alan G. Glaros

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacokinetics of an Indinavir-Ritonav

✍ Dr. Ighovwerha Ofotokun; Dr. Edward P. Acosta; Dr. Jeffrey L. Lennox; Ms. Yi Pan 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 95 KB

Effects of Esomeprazole on the Pharmacok

✍ Jennifer J. Kiser; Kenneth A. Lichtenstein; Peter L. Anderson; Courtney V. Fletc 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 52 KB

Pharmacokinetic Characteristics of Riton

✍ Courtney V. Fletcher; Ram Yogev; Sharon A. Nachman; Andrew Wiznia; Stephen Pelto 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 832 KB

Pharmacokinetics, safety and bioavailabi

✍ M. Wachsman; B.G. Petty; K.C. Cundy; H.S. Jaffe; P.E. Fisher; A. Pastelak; P.S. 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 677 KB

A pharmacokinetic study of intermittent

✍ Gallicano, K 📂 Article 📅 2001 🏛 Nature Publishing Group 🌐 English ⚖ 110 KB

Rifampin pharmacokinetics in children, w

✍ Hendrik Simon Schaaf; Marianne Willemse; Karien Cilliers; Demetre Labadarios; Jo 📂 Article 📅 2009 🏛 BioMed Central 🌐 English ⚖ 331 KB